1. Home
  2. ACXP
  3. ACXP News

Latest Acurx Pharmaceuticals Inc. (ACXP) News on January 19, 2025

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ACXP

PR Newswire

11 days ago

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

ACXP

MT Newswires

12 days ago

Acurx Launches $2.5 Million Registered Direct Offering; Shares Fall After-Hours

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ACXP

PR Newswire

12 days ago

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)
ACXP

PR Newswire

13 days ago

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
ACXP

Zacks

16 days ago

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?

ACXP

ACCESSWIRE

a month ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications
ACXP

PR Newswire

a month ago

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now
ACXP

Zacks

2 months ago

Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now

ACXP

ACCESSWIRE

2 months ago

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000
ACXP

Barrons.com

2 months ago

MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
ACXP

PR Newswire

2 months ago

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update
ACXP

PR Newswire

2 months ago

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update

ACXP

GuruFocus.com

2 months ago

Acurx Pharmaceuticals Inc (ACXP) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update
ACXP

PR Newswire

2 months ago

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
ACXP

ACCESSWIRE

3 months ago

New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
ACXP

ACCESSWIRE

3 months ago

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference
ACXP

PR Newswire

3 months ago

Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement
ACXP

PR Newswire

3 months ago

Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement

Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024
ACXP

PR Newswire

3 months ago

Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024

New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
ACXP

ACCESSWIRE

3 months ago

New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support

New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST
ACXP

ACCESSWIRE

3 months ago

New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST

New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST
ACXP

ACCESSWIRE

3 months ago

New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST

Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues
ACXP

PR Newswire

4 months ago

Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues

Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium
ACXP

PR Newswire

4 months ago

Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile Symposium

New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
ACXP

ACCESSWIRE

4 months ago

New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET

ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference
ACXP

PR Newswire

5 months ago

ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference

We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate
ACXP

Simply Wall St.

5 months ago

We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate

New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT
ACXP

GlobeNewswire

5 months ago

New to The Street Announces Episode 590, Five Corporate Interviews, Airing on the Fox Business Network, Tonight Monday, August 19, 2024, at 10:30 PM PT

New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET
ACXP

GlobeNewswire

5 months ago

New to The Street TV Announces Episode 583, Five Riveting Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Saturday, August 10, 2024, at 6:30 PM ET

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update
ACXP

PR Newswire

5 months ago

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2024 Results and Provides Business Update

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome
ACXP

PR Newswire

6 months ago

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome

Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update
ACXP

PR Newswire

6 months ago

Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference
ACXP

PR Newswire

6 months ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT
ACXP

GlobeNewswire

7 months ago

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT

ACXP

GuruFocus.com

8 months ago

Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...

ACXP

Thomson Reuters StreetEvents

8 months ago

Q1 2024 Acurx Pharmaceuticals Inc Earnings Call

Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
ACXP

PR Newswire

8 months ago

Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
ACXP

PR Newswire

8 months ago

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference
ACXP

PR Newswire

9 months ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
ACXP

PR Newswire

9 months ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update
ACXP

PR Newswire

9 months ago

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

ACXP

Newsfile

10 months ago

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
ACXP

Insider Monkey

10 months ago

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

ACXP

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Acurx Pharmaceuticals Inc Earnings Call

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully
ACXP

Simply Wall St.

10 months ago

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
ACXP

PR Newswire

10 months ago

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update
ACXP

PR Newswire

a year ago

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development
ACXP

PR Newswire

a year ago

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series
ACXP

GlobeNewswire

a year ago

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT
ACXP

GlobeNewswire

a year ago

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT
ACXP

GlobeNewswire

a year ago

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT
ACXP

GlobeNewswire

a year ago

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

REPLAY- AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat
ACXP

IPO-Edge.com

a year ago

REPLAY- AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
ACXP

PR Newswire

a year ago

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT
ACXP

GlobeNewswire

a year ago

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer
ACXP

GlobeNewswire

a year ago

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024
ACXP

PR Newswire

a year ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT
ACXP

GlobeNewswire

a year ago

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

Industrial Logistics Properties Trust's Dividend Analysis
ACXP

GuruFocus.com

a year ago

Industrial Logistics Properties Trust's Dividend Analysis

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?
ACXP

Benzinga

a year ago

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
ACXP

PR Newswire

a year ago

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

Industrial Logistics Properties Trust Announces 2023 Dividend Allocation
ACXP

Business Wire

a year ago

Industrial Logistics Properties Trust Announces 2023 Dividend Allocation

Sidoti Events, LLC's Virtual January Micro-Cap Conference
ACXP

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACXP

The Economist

a year ago

AI can transform education for the better

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares
ACXP

Business Wire

a year ago

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer
ACXP

GlobeNewswire

a year ago

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023
ACXP

ACCESSWIRE

a year ago

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
ACXP

GlobeNewswire

a year ago

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024
ACXP

InvestorPlace

a year ago

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024

SYLA’s Rimawari-kun Platform’s Gross Merchandise Value Surpasses Five Billion Yen
ACXP

GlobeNewswire

a year ago

SYLA’s Rimawari-kun Platform’s Gross Merchandise Value Surpasses Five Billion Yen

Smart Share Global Limited Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period
ACXP

GlobeNewswire

a year ago

Smart Share Global Limited Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue
ACXP

Simply Wall St.

a year ago

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Mama`s Creations Inc (MAMA) Reports Strong Revenue and Net Income Growth in Q3 Fiscal 2024
ACXP

GuruFocus.com

a year ago

Mama`s Creations Inc (MAMA) Reports Strong Revenue and Net Income Growth in Q3 Fiscal 2024

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock
ACXP

PR Newswire

a year ago

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

Mama’s Creations Reports Third Quarter Fiscal 2024 Financial Results
ACXP

GlobeNewswire

a year ago

Mama’s Creations Reports Third Quarter Fiscal 2024 Financial Results

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting
ACXP

PR Newswire

a year ago

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?
ACXP

Zacks

a year ago

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report
ACXP

Business Wire

a year ago

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

Wind, Climate Change, And The Future
ACXP

ACCESSWIRE

a year ago

Wind, Climate Change, And The Future

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
ACXP

ACCESSWIRE

a year ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024
ACXP

Business Wire

a year ago

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024

Smart Share Global Limited (NASDAQ:EM) Q3 2023 Earnings Call Transcript
ACXP

Insider Monkey

a year ago

Smart Share Global Limited (NASDAQ:EM) Q3 2023 Earnings Call Transcript

ACXP

Business Wire

a year ago

Broadway Financial Corporation Announces Notification From Nasdaq Regarding Delinquent Form 10-Q

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference
ACXP

GlobeNewswire

a year ago

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

OFS Credit Company Provides October 2023 Net Asset Value Update
ACXP

Business Wire

a year ago

OFS Credit Company Provides October 2023 Net Asset Value Update

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?
ACXP

Zacks

a year ago

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

Bakkt Reports Third Quarter 2023 Results
ACXP

Business Wire

a year ago

Bakkt Reports Third Quarter 2023 Results

Lument Finance Trust Reports Third Quarter Results
ACXP

PR Newswire

a year ago

Lument Finance Trust Reports Third Quarter Results

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®
ACXP

GlobeNewswire

a year ago

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

Bakkt Announces Expansion of International Footprint and Custody Client Base
ACXP

Business Wire

a year ago

Bakkt Announces Expansion of International Footprint and Custody Client Base

ACXP

GuruFocus.com

a year ago

Xtant Medical Holdings Inc (XTNT) Reports Record Q3 Revenue and Raises 2023 Guidance

Xtant Medical Announces Record Third Quarter Revenue of $25 Million
ACXP

GlobeNewswire

a year ago

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

Vaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business Updates
ACXP

GuruFocus.com

a year ago

Vaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business Updates

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023
ACXP

GlobeNewswire

a year ago

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference
ACXP

Business Wire

a year ago

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference

Share on Social Networks: